NKECHI OKWARA: Open Payments
NPI 1699162016 · GLENN DALE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$235 in 2 payments from 2 companies in 2025. Trend: 2023 $0 · 2024 $299 · 2025 $235
Food & beverage: $235
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 1 | $120 |
| Neurocrine BioSciences, Inc. | 1 | $114 |
Products named: REPATHA, INGREZZA.
Industry payments across MD — which companies pay providers there.
